InsiderClue
Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

TransMedics Group, Inc.

TMDX Clue Score83
United States Fiscal year ends December CIK 0001756262 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
David Weill
11 Sep 2026
Director
Buy
1,336
$81.63
$109.06K
Thomas J. Gunderson
15 Jun 2026
Director
Sold after exercise
9,624
$75.06
$722.38K
Gerardo Hernandez
4 Mar 2026
Chief Financial Officer
Sold after exercise
5,912
$147.21
$870.31K
Gerardo Hernandez
4 Mar 2026
Chief Financial Officer
Sold after exercise
1,324
$147.21
$194.91K
David Weill
4 Mar 2026
Director
Sold after exercise
3,571
$146.82
$524.29K
Stephanie Lovell
4 Mar 2026
Director
Sell
1,193
$149.62
$178.50K
Nicholas Corcoran
2 Mar 2026
See remarks
Sell
2,966
$139.12
$412.63K
Anil P. Ranganath
2 Mar 2026
See remarks
Sell
864
$139.12
$120.20K
Gerardo Hernandez
2 Mar 2026
Chief Financial Officer
Sell
375
$139.12
$52.17K
Gerardo Hernandez
4 Dec 2025
Chief Financial Officer
Sell
920
$139.62
$128.45K
David Weill
3 Dec 2025
Director
Sold after exercise
5,000
$138.64
$693.20K
Anil P. Ranganath
25 Nov 2025
See remarks
Sold after exercise
3,000
$145.22
$435.66K
Waleed H Hassanein
17 Nov 2025
President & CEO
Buy indirect
8,775
$114.00
$1.00M

What was left out

Form 4 filings counted 25
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 6
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 205,632
History held since 6 May 2019